Purdue Pharma and its controlling Sackler family have offered a new settlement to resolve lawsuits ... % spike in deaths in the 12 months to April 2021 to nearly 100,000. The latest deal still ...

A judge in the US has rejected the bankruptcy plan proposed by Purdue Pharma to settle ... want to jeopardise what was on offer by seeking further changes. The settlement would set up a fund ...

Purdue Pharma has filed a new bankruptcy plan ... was blocked by the US Supreme Court. The current settlement does not offer an automatic liability shield to the family. The current settlement ...

Purdue Pharma, maker of opioid painkiller OxyContin, agreed to pay $150 million to multiple levels of Canada’s government in a landmark 2022 settlement. Poilievre added that he’ll downsize the ...

Supreme Court hears case that could shield Purdue Pharma owners from opioid lawsuits ... Court to decide on legality of OxyContin maker’s settlement plan with victims of opioid crisis The ...

with the most recent being the $7.4 billion announced in January by Purdue Pharma and its owners, the Sackler family. In the Purdue Pharma/Sackler settlement, Pennsylvania will receive $212 million.

Teva's $4.25B opioid settlement gets support from 48 states and will move forward Viatris was formed in 2020 as a merger between Mylan and Pfizer’s generics unit Upjohn. In a 2021 filing (PDF ...

In the Purdue Pharma/Sackler settlement, Pennsylvania will receive $212 million. It wasn’t immediately clear where the settlement would be filed, or other details beyond Viatris’ news release.

The lawsuit seeks more than $50 million in damages. Sharpe's attorney, Lanny Davis, said the accuser turned down a $10 million settlement before filing suit. Sharpe's accuser has retained Tony ...